These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 7843344)

  • 21. VIDEOFAR: an epidemiologic tool for drug utilization studies.
    Raschetti R
    Ann Ist Super Sanita; 1991; 27(2):191-3. PubMed ID: 1755569
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trends in prescribing calcium-channel blockers. GIFA Investigators. Gruppo Italiano di Farmacovigilanza nell'Anziano.
    Incalzi RA; Pedone C; Carbonin PU
    Lancet; 1998 Nov; 352(9139):1557. PubMed ID: 9820337
    [No Abstract]   [Full Text] [Related]  

  • 23. Descriptive tools and analysis.
    Capellà D
    WHO Reg Publ Eur Ser; 1993; 45():55-78. PubMed ID: 8442851
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparing drug classification systems.
    Mahoney A; Evans J
    AMIA Annu Symp Proc; 2008 Nov; ():1039. PubMed ID: 18999016
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New approaches to analysing prescription data and to transfer pharmacoepidemiological and evidence-based reports to prescribers.
    Addis A; Magrini N
    Pharmacoepidemiol Drug Saf; 2002 Dec; 11(8):721-6. PubMed ID: 12512250
    [No Abstract]   [Full Text] [Related]  

  • 26. Medication use as evidence for pharmacotherapeutics curriculum content.
    Pitman SK; Sorofman B
    Am J Pharm Educ; 2009 Dec; 73(8):148. PubMed ID: 20221341
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The potential of the European network of congenital anomaly registers (EUROCAT) for drug safety surveillance: a descriptive study.
    Meijer WM; Cornel MC; Dolk H; de Walle HE; Armstrong NC; de Jong-van den Berg LT;
    Pharmacoepidemiol Drug Saf; 2006 Sep; 15(9):675-82. PubMed ID: 16761260
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Systematic Review of Coding Systems Used in Pharmacoepidemiology and Database Research.
    Chen Y; Zivkovic M; Wang T; Su S; Lee J; Bortnichak EA
    Methods Inf Med; 2018 Feb; 57(1):1-42. PubMed ID: 29621836
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Benzodiazepines with different half-life and falling in a hospitalized population: The GIFA study. Gruppo Italiano di Farmacovigilanza nell'Anziano.
    Passaro A; Volpato S; Romagnoni F; Manzoli N; Zuliani G; Fellin R
    J Clin Epidemiol; 2000 Dec; 53(12):1222-9. PubMed ID: 11146268
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trade names and generic names. Problems for prescribing physicians.
    Hemminki E; Enlund H; Hellevuo K; Laurila R; Turakka H
    Scand J Prim Health Care; 1984 May; 2(2):84-7. PubMed ID: 6544453
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Medication use characteristics in the elderly: the Iowa 65+ Rural Health Study.
    Helling DK; Lemke JH; Semla TP; Wallace RB; Lipson DP; Cornoni-Huntley J
    J Am Geriatr Soc; 1987 Jan; 35(1):4-12. PubMed ID: 3794145
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug prescription in pregnancy: analysis of a large statutory sickness fund population.
    Egen-Lappe V; Hasford J
    Eur J Clin Pharmacol; 2004 Nov; 60(9):659-66. PubMed ID: 15480609
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prescription of drugs during pregnancy in France.
    Lacroix I; Damase-Michel C; Lapeyre-Mestre M; Montastruc JL
    Lancet; 2000 Nov; 356(9243):1735-6. PubMed ID: 11095263
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Age and severe adverse drug reactions caused by nifedipine and verapamil. Gruppo Italiano di Farmacovigilanza nell' Anziano (GIFA).
    Pahor M; Manto A; Pedone C; Carosella L; Guralnik JM; Carbonin P
    J Clin Epidemiol; 1996 Aug; 49(8):921-8. PubMed ID: 8699214
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of medications by persons 65 and over: data from the established populations for epidemiologic studies of the elderly.
    Chrischilles EA; Foley DJ; Wallace RB; Lemke JH; Semla TP; Hanlon JT; Glynn RJ; Ostfeld AM; Guralnik JM
    J Gerontol; 1992 Sep; 47(5):M137-44. PubMed ID: 1512428
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Framework and development of a comprehensive drug product coding system.
    DeVito CA; Aldridge GW; Wilson A; Vidis JS; Goldberg T; Dickson WM; Moore WE
    Contemp Pharm Pract; 1979; 2(2):62-5. PubMed ID: 10316818
    [No Abstract]   [Full Text] [Related]  

  • 37. [Public health research with statutory health insurance drug data].
    Janhsen K
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2004 Jun; 47(6):521-5. PubMed ID: 15221100
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Information systems for the analysis of drug prescriptions in Spain.
    Ferrando MC
    Ann Ist Super Sanita; 1991; 27(2):213-6. PubMed ID: 1755573
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of drug products available in Germany and the United States.
    Grabenstein JD
    Mil Med; 1990 Mar; 155(3):133-7. PubMed ID: 2107469
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pharmaco-epidemiologic indicators for the analysis of drug consumption at the regional level].
    Pinto A; Panei P; Traversa G; Bassi G
    Ann Ist Super Sanita; 2000; 36(3):363-7. PubMed ID: 11293305
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.